These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Bueno L; de Ponti F; Fried M; Kullak-Ublick GA; Kwiatek MA; Pohl D; Quigley EM; Tack J; Talley NJ Neurogastroenterol Motil; 2007 Jan; 19(1 Suppl):89-119. PubMed ID: 17280587 [TBL] [Abstract][Full Text] [Related]
4. Sensation and gas dynamics in functional gastrointestinal disorders. Malagelada JR Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i72-5. PubMed ID: 12077071 [TBL] [Abstract][Full Text] [Related]
5. The role of fat and cholecystokinin in functional dyspepsia. Fried M; Feinle C Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i54-7. PubMed ID: 12077066 [TBL] [Abstract][Full Text] [Related]
10. Influence of acute tryptophan depletion on gastric sensorimotor function in humans. Geeraerts B; Van Oudenhove L; Boesmans W; Vos R; Vanden Berghe P; Tack J Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G228-35. PubMed ID: 20884888 [TBL] [Abstract][Full Text] [Related]
11. [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders]. Cervio E; Rondanelli M; Balestra B; Dellabianca A; Agazzi A; Giacosa A; Tonini M Recenti Prog Med; 2007 Feb; 98(2):69-73. PubMed ID: 17439064 [TBL] [Abstract][Full Text] [Related]
12. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Delvaux M Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i67-71. PubMed ID: 12077070 [TBL] [Abstract][Full Text] [Related]
13. Serotonin and the GI tract. Hasler WL Curr Gastroenterol Rep; 2009 Oct; 11(5):383-91. PubMed ID: 19765366 [TBL] [Abstract][Full Text] [Related]
14. Central serotonergic and noradrenergic receptors in functional dyspepsia. O'Mahony S; Dinan TG; Keeling PW; Chua AS World J Gastroenterol; 2006 May; 12(17):2681-7. PubMed ID: 16718753 [TBL] [Abstract][Full Text] [Related]
15. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Grundy D Gut; 2002 Jul; 51 Suppl 1(Suppl 1):i2-5. PubMed ID: 12077054 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders. Kindt S; Tack J Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():32-9. PubMed ID: 17620086 [TBL] [Abstract][Full Text] [Related]
18. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Raybould HE; Glatzle J; Robin C; Meyer JH; Phan T; Wong H; Sternini C Am J Physiol Gastrointest Liver Physiol; 2003 Mar; 284(3):G367-72. PubMed ID: 12409280 [TBL] [Abstract][Full Text] [Related]
19. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Delgado-Aros S; Chial HJ; Camilleri M; Szarka LA; Weber FT; Jacob J; Ferber I; McKinzie S; Burton DD; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G558-66. PubMed ID: 12631557 [TBL] [Abstract][Full Text] [Related]